Find the name
- Find the name
- In the exact answer text
- Check identity
- In the relevant register and document
- Assess the follow-up
- With the responsible team and documented source
Pharmaceutical industry
Pharmaceuticals: product claims compared with approved facts
Medical information and regulatory teams need to know which claims circulate about their products. Bring AI answers, exposed sources and approved facts together to identify passages requiring review and prepare documented information for the responsible specialists.
The text to review
Read the warning in its official source.
A short answer may omit a warning or describe it without context. Open the full text and compare it with the relevant official document: comparison with approved facts supports review without determining clinical suitability or completeness of medical information.
Elements of an illustrative case for specialist review, without automatic clinical judgments.
| Case element | Reference to retain |
|---|---|
| Observed answer | The question, the text, the assistant and the date |
| Official document | Relevant version and passage to read |
| Specialist assessment | The person responsible and the follow-up of the report |
Distinct products
A similar name does not identify the same product.
Similar names, different forms and documents from another country require separate attention. Check product identity against the relevant register and approved facts before assigning a statement to your portfolio or preparing a correction.
A process to verify the identity of the named product, separate from the medical assessment of the product itself.
Information to review
A correction remains information to validate.
An inaccurate source is not corrected with a promotional claim. The proposal shows line by line what comes out, what goes in and why, with its source, using only approved facts; approval, publication and new observation remain separate steps.
For the responsible team
Medical information teams’ questions about monitoring.
Reference documents, comparison limits and text review: three points to clarify before using observed answers in regulatory work, keeping monitoring separate from clinical advice.
Is comparison with approved facts a clinical assessment?
No. It reports consistency and conflicts within the method’s limits; unverifiable content remains identified. Clinical and regulatory assessment belongs to responsible specialists.
Does a citation explain why the model answered that way?
It shows the reference exposed by the assistant. It does not by itself prove how the sentence was generated; the team reviews the cited text and other available evidence.
Who approves communication prepared after a check?
The company’s responsible functions under their own process. A draft or Action Center proposal does not replace medical and regulatory review or authorise publication.
Related paths
After “Pharmaceuticals”, the next step.
Each role uses the platform with a different goal. From here you compare the other solutions, the path from brand to verification and the methodology behind the numbers.
AI visibility in healthcare
Services, official sources and industry rules: which claims reach people about your facility and how to correct them without stepping outside the regulations.
ReadFrom question to action
Learn how to use TrustInsider: choose the brand and the questions, read the collected answers, update your content and compare the results.
ReadA transparent method, not a black box
How every TrustInsider measure is built: sampling of AI answers, sources and rights, index calculation and declared limits.
ReadFind the right answer
Help with access, credits, collections, integrations and data: guides, FAQs, the site assistant and support requests from your workspace.
Read